Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Vasogen-- VAS on TSE -- Ignore unavailable to you. Want to Upgrade?

To: stevie who wrote (84)	12/18/1997 11:29:00 AM
From: chrisco	Read Replies (1) \| Respond to of 377

STEVIE check the biotech sector here there is a co. in calif. doing something with Ozone therapy

To: stevie who wrote (84)	12/18/1997 7:27:00 PM
From: Syncrude	Read Replies (1) \| Respond to of 377

There is a company called Medizone International. It does research and development for ozone-based treatment of deseases caused by lipid enveloped viruses including AIDS, Hepatitis B, Herpes; AND IN THE DEVELOPMENT OF ITS PATENTED TECHNOLOGY FOR THE DECONTAMINATION OF BLOOD AND BLOOD PRODUCTS. While not directly competing with Vasogen, it is important to recognize that ozone solutions are not the monopoly of Vasogen. There are other companies out there doing R&D on ozone. Nothing prevents another company from directing attention to Vasogen's area of expertise if Vasogen starts generating interest and revenues.